|
2020 Conference Publication Patient-reported outcome (PRO) results from AGITG DOCTOR: A randomised phase II trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinomaMercieca-Bebber, R., Barnes, E. H., Wilson, K., Samoon, Z., Walpole, E. T., Mai, T., Ackland, S., Burge, M., Dickie, G., Watson, D., Leung, J., Wang, T., Bohmer, R., Cameron, D., Simes, R., Gebski, V., Smithers, M., Thomas, J., Zalcberg, J. R. and Barbour, A. (2020). Patient-reported outcome (PRO) results from AGITG DOCTOR: A randomised phase II trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma. ESMO Virtual Congress, Electr Network, Sep 19-Oct 18, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.08.1936 |
|
2020 Conference Publication Sentinel Lymph Node Biopsy in Melanoma is Therapeutic: Predictors of Long-Term Node Basin Control with SLN Biopsy AloneCrystal, J., Thompson, J. F., Cochran, A. J., Hyngstrom, J., Caraco, C., Zager, J. S., Jahkola, T., Beitsch, P. D., Moncrieff, M., Ingvar, C., Levine, E., Agnese, D., Henderson, M. A., Dummer, R., Rossi, C., Wright, F., Byrd, D., Matter, M., Ross, A. M., Hsueh, E., Johnson, D. B., Terheyden, P., Wayne, J. D., Huston, T., Smithers, M., Ariyan, C. E., Schneebaum, S., Jacobs, L. K., McMasters, K. M. ... Faries, M. B. (2020). Sentinel Lymph Node Biopsy in Melanoma is Therapeutic: Predictors of Long-Term Node Basin Control with SLN Biopsy Alone. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-Center AnalysisKroon, H. M., Kenyon-Smith, T., Miura, J. T., Teras, J., Beasley, G. M., Mullen, D., Farrow, N. E., Mosca, P., Lowe, M. C., Farley, C. R., Kim, Y., Naqvi, S. M., Potdar, A., Daou, H., Sun, J., Farma, J. M., Henderson, M. A., Speakman, D., Serpell, J., Delman, K. A., Smithers, M., Coventry, B. J., Tyler, D. S., Zager, J. S. and Thompson, J. F. (2020). Factors Predicting Toxicity and Response Following Isolated Limb Infusion for Melanoma: An International Multi-Center Analysis. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and AustraliaSun, J., Kroon, H. M., Miura, J. T., Beasley, G. M., Farrow, N. E., Mosca, P., Lowe, M. C., Farley, C. R., Kim, Y., Naqvi, S. M., Carr, M. J., Kirichenko, D., Potdar, A., Daou, H., Mullen, D., Farma, J. M., Henderson, M. A., Serpell, J., Delman, K. A., Smithers, M., Coventry, B. J., Tyler, D. S., Thompson, J. F. and Zager, J. S. (2020). Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication The Utility of Ultrasound in the Follow-up of Patients with Melanoma Sentinel Node Metastases Undergoing Observation: An Analysis of MSLT-IIGarland-Kledzik, M., Thompson, J. F., Cochran, A. J., Hyngstrom, J., Caraco, C., Zager, J. S., Jahkola, T., Beitsch, P. D., Moncrieff, M., Ingvar, C., Levine, E., Henderson, M. A., Dummer, R., Rossi, C., Wright, F., Byrd, D., Matter, M., Ross, A. M., Hsueh, E., Johnson, D. B., Terheyden, P., Wayne, J. D., Huston, T., Smithers, M., Ariyan, C. E., Schneebaum, S., Jacobs, L. K., McMasters, K., Gesierich, A. ... Faries, M. B. (2020). The Utility of Ultrasound in the Follow-up of Patients with Melanoma Sentinel Node Metastases Undergoing Observation: An Analysis of MSLT-II. Society-of-Surgical-Oncology (SSO) International Conference on Surgical Cancer Care, Boston Ma, Mar 25-28, 2020. NEW YORK: SPRINGER. |
|
2020 Conference Publication Highlights of the 2019 Annual Academic Surgery ConferenceDi Bella, Claudia, Lee, James C., Koh, Cherry E., Mukherjee, Payal and Smithers, Mark (2020). Highlights of the 2019 Annual Academic Surgery Conference. 2019 Annual Academic Surgery Conference, Melbourne, VIC, Australia, 7-8 November 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ans.15713 |
|
2019 Conference Publication A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]Xu, Wen, Poulsen, Michael, Atkinson, Victoria, Fogarty, Gerald, Veness, Michael, Smithers, Bernard, Gyorki, David, Mar, Victoria, Howle, Julie, Guminski, Alexander, Williams, Narelle and Paton, Elizabeth (2019). A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]. HOBOKEN: WILEY. |
|
2019 Conference Publication An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neckFoote, Matthew, Smithers, Mark, Hong, Angela, Fogarty, Gerald, Scolyer, Richard, Paton, Elizabeth, Barker, Christopher, Chua, Margaret, Shannon, Kerwin, Burmeister, Bryan, Nobes, Jenny and Williams, Narelle (2019). An international randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck. HOBOKEN: WILEY. |
|
2019 Conference Publication ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neckFoote, M., Smithers, M., Hong, A., Fogarty, G., Scolyer, R., Paton, E., Barker, C., Chua, M., Shannon, K., Burmeister, B. and Nobes, J. (2019). ANZMTG 01.09 An International randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck. HOBOKEN: WILEY. |
|
2019 Conference Publication Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-IRand, J. G., Kirchoff, D., Deutsch, G., Stern, S., Thompson, J., Cochran, A., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Sondak, V., Coventry, B., Kashani-Sabet, M., Smithers, M., Paul, E., Kraybill, W., Elashoff, R., Lee, D. and Faries, M. B. (2019). Obesity Paradox in Early Stage Melanoma: Long-Term Follow-up in MSLT-I. 72nd Annual Cancer Symposium of the Society-of-Surgical-Oncology (SSO), San Diego Ca, Mar 27-30, 2019. NEW YORK: SPRINGER. |
|
2019 Conference Publication Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibitionAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan, Shirai, Keisuki, Essner, Richard, Smithers, Bernard M., Atkinson, Victoria, Sarson, David and Wachter, Eric A. (2019). Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibition. LONDON: BMC. |
|
2019 Conference Publication FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapyTrada, Y., Law, P. W., Bernard, A., Foote, M. C., Barbour, A., Lambie, D., Smithers, M., Burmeister, B. and Pinkham, M. B. (2019). FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapy. 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Chicago, Illinois, 15-18 September 2019 . Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.ijrobp.2019.06.2489 |
|
2019 Conference Publication Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysisMiura, J. T., Kroon, H. M., Beasley, G., Farrow, N. E., Mosca, P. J., Lowe, M., Farley, C., Kim, Y., Naqvi, S., Potdar, A., Daou, H., Sun, J., Mullen, D., Farma, J., Henderson, M., Serpell, J., Delman, K. A., Smithers, M., Coventry, B., Tyler, D. S., Thompson, J. and Zager, J. (2019). Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysis. 72nd Annual Cancer Symposium of the Society of Surgical Oncology (SSO), San Diego, California, 27-30 March 2019 . New York, NY, United States: Springer. |
|
2019 Conference Publication SOX18 activation in primary melanoma tumoursChong, S., Rowe, C., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2019). SOX18 activation in primary melanoma tumours. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2019 Conference Publication Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanomaAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan S., Shirai, Keisuke, Essner, Richard, Smithers, Bernard Mark, Atkinson, Victoria and Wachter, Eric Andrew (2019). Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il, United States, May 31-June 4, 2019. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2019.37.15_suppl.9559 |
|
2019 Conference Publication Clinicopathological factors associated with death from thin (<= 1 mm) melanomaClaeson, M., Baade, P., Brown, S., Soyer, P., Smithers, M., Green, A., Whiteman, D. and Khosrotehrani, K. (2019). Clinicopathological factors associated with death from thin ( |
|
2019 Conference Publication IRF4 rs12203592*T/T genotype is associated with nodular melanomaRayner, Jenna E., McMeniman, Erin K., Duffy, David L., De'Ambrosis, Brian, Smithers, B Mark, Jagirdar, Kasturee, Lee, Katie J., Soyer, H. Peter and Sturm, Richard A. (2019). IRF4 rs12203592*T/T genotype is associated with nodular melanoma. ASDR Annual Scientific Meeting 2019, Melbourne, VIC, Australia, 16-17 May 2019. |
|
2019 Conference Publication Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanomaTie, Emilia Nan, Lai-Kwon, Julia Elizabeth, Na, Lumine, Rtshiladze, Michael Alexander, Bozzi, James, Read, Tavis, Atkinson, Victoria, Au-Yeung, George, Long, Georgina V., McArthur, Grant A., Sandhu, Shahneen Kaur, Saw, Robyn, Walpole, Euan Thomas, Menzies, Alexander M., Smithers, B. Mark and Gyorki, David E. (2019). Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL United States, 31 May - 4 June 2019. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2019 Conference Publication Melanoma patient survival: Prognostic value of pSTAT5 as a biomarkerChong, S., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2019). Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2018 Conference Publication Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinomaBarbour, A. P., Walpole, E. T., Mai, G. T., Barnes, L., Watson, D. I., Ackland, S. P., Wills, V., Martin, J., Burge, M., Karapetis, C. S., Shannon, J., Nott, L. M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J. R., Simes, J. and Smithers, M. (2018). Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma. 43rd ESMO Congress (ESMO), Munich Germany, Oct 19-23, 2018. OXFORD: OXFORD UNIV PRESS. |
